Holly Ellyatt, CNBC, Nov. 30, 2021 KEY POINTS There are many unknowns surrounding the new omicron Covid variant; there are early signs it’s more transmissible but we don’t yet know what risks it poses to public health. Global market sentiment …
Revisiting common COVID-19 vaccine questions
Ali Whittier, CHES®, BCBST WellTuned, Nov. 30, 2021 Prior to the COVID-19 pandemic, many people hadn’t needed to grasp the sophisticated way our immune systems work and exactly how vaccines partner with this system to keep us safe. But as many continue to face …
Tennessee reaches 50% fully vaccinated for COVID-19
Slater Teague, WJHL-TV, Nov. 29, 2021 The Tennessee Department of Health reported 131 new COVID-19 cases, two new deaths, and 120 new inactive/recovered cases in Northeast Tennessee on Monday. Over the past three days, the region added 380 new cases …
How vaccine-makers plan to address the new COVID-19 omicron variant
Dustin Jones, NPR, Nov. 28, 2021 A new strain of COVID-19 first discovered in South Africa was declared a variant of concern by the World Health Organization on Friday. Here’s how the pharmaceutical industry plans to address the latest coronavirus …
Pfizer said an updated version of its COVID-19 vaccine will be ‘ready in 100 days’ if the new Omicron variant is resistant to its current vaccine
Yelena Dzhanova, Business Insider, Nov. 27, 2021 Pfizer said it will be able to manufacture and distribute an updated version of its COVID-19 vaccine within 100 days if the new variant Omicron is found to be resistant to its current …